<DOC>
	<DOCNO>NCT00921752</DOCNO>
	<brief_summary>To demonstrate high percent rate achieve target lipid goal among patient high cardiovascular risk use potent lipid-lowering treatment option include high-potency statin combination therapy .</brief_summary>
	<brief_title>C2 -CORVUS Cholesterol-Control ( C2 ) Controlled Targets High Vascular Risk Patients Using Effective Statins ( CORVUS )</brief_title>
	<detailed_description />
	<criteria>Patients high cardiovascular risk accord Framingham SCORE rate Not eligible lipid statin therapy Intolerance therapy Patients low intermediate CV risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Lipid therapy</keyword>
	<keyword>high CV risk</keyword>
	<keyword>lipid goal attainment</keyword>
	<keyword>High cardiovascular risk patient</keyword>
</DOC>